To develop new strategies for AD treatment, we investigated in this study the interaction of Aβ42 and its aggregates with BDNF, examined the effects of these Aβ42 species on the cytological potency of extracellular BDNF, and explored the roles of BOs and CAs in these processes. Here, BDNF is linked to Alzheimer disease.